Folacin-800 Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Folacin-800
P
- pafolacianine
- Palcaps 10 (pancrelipase)
- Pan-2400 (pancreatin)
- Panase (pancrelipase)
- Pancrease (pancrelipase)
- Pancrease MT (pancrelipase)
- Pancrease MT 10 (pancrelipase)
- Pancrease MT 16 (pancrelipase)
- Pancrease MT 20 (pancrelipase)
- Pancrease MT 4 (pancrelipase)
- Pancreatil-UL 12 (pancrelipase)
- pancreatin
- Pancreatin 4X (pancreatin)
- Pancreaze (pancrelipase)
- Pancrecarb MS (pancrelipase)
- Pancrecarb MS-16 (pancrelipase)
- Pancrecarb MS-4 (pancrelipase)
- Pancrecarb MS-8 (pancrelipase)
- pancrelipase
- Pancron D/R (pancrelipase)
- Pangestyme CN 10 (pancrelipase)
- Pangestyme CN 20 (pancrelipase)
- Pangestyme EC (pancrelipase)
- Pangestyme MT 16 (pancrelipase)
- Pangestyme UL 18 (pancrelipase)
- Pangestyme UL 20 (pancrelipase)
- Panocaps (pancrelipase)
- Panocaps MT 16 (pancrelipase)
- Panokase (pancrelipase)
- Panokase 16 (pancrelipase)
- PB-Hyos (atropine / hyoscyamine / phenobarbital / scopolamine)
- Pediazole (erythromycin / sulfisoxazole)
- Peganone (ethotoin)
- Pertzye (pancrelipase)
- phenazopyridine / sulfamethoxazole
- phenazopyridine / sulfisoxazole
- phenobarbital
- Phenohytro (atropine / hyoscyamine / phenobarbital / scopolamine)
- phensuximide
- Phenytek (phenytoin)
- phenytoin
- Phenytoin Sodium (phenytoin)
- Phenytoin Sodium, Extended Release (phenytoin)
- Phenytoin Sodium, Prompt (phenytoin)
- Plaretase (pancrelipase)
- Prevalite (cholestyramine)
- primidone
- Primsol (trimethoprim)
- Proloprim (trimethoprim)
- Protilase (pancrelipase)
- Protilase MT-16 (pancrelipase)
- pyrimethamine
- pyrimethamine / sulfadoxine
More about Folacin-800 (folic acid)
- Folacin-800 consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: vitamins
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.